Article · 31 Dec 2025
OtherPublished 5 Feb 2012
Overview on the efficacy and safety of gadobutrol: an MRI contrast agent for the CNS, body and vessels
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extracellular macrocyclic contrast agent of high stability, is indicated for contrast-enhanced MRI of adults, adolescents and children 2 years of age and older. Gadobutrol offers increased T1 relaxivity, which improves MR image quality and clinical use of the technique.
Subjects
Radiology & ImagingAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Imaging in Medicine.
Article · 28 Feb 2025
AI Enhanced CPR Revolutionizing Resuscitation with Intelligent Intervention
Article · 28 Feb 2025
Teleradiology: Transforming Medical Imaging in the Digital Age
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImaging in Medicine
- SubjectRadiology & Imaging
- BylineArticles whose byline prints “Juan E Gutierrez”
- BylineArticles whose byline prints “Sara Koenig”
- BylineArticles whose byline prints “Josy Breuer”